Skip to main content
. Author manuscript; available in PMC: 2024 Mar 26.
Published in final edited form as: Clin Chem. 2023 Dec 1;69(12):1409–1419. doi: 10.1093/clinchem/hvad173

Table 2.

Baseline characteristics of adult (TBAIT) and children (P1041) TB/HIV cohorts.

TBAIT cohort (adult, n = 34)a,b
P1041 cohort (children, n = 17)a,b
HIV+ (n = 14) HIV− (n = 20) TB+ (n = 23) TB− (n = 11) HIV+ (n = 9) HIV− (n = 8) TB+ (n = 9) TB− (n = 8)
Female sex 5 (35.7) 7 (35.0) 5 (21.7) 7 (63.6) 6 (66.7) 3 (37.5) 6 (66.7) 3 (37.5)
Age (years for adult, days for child) 38 (27–42) 35 (27–42) 35 (27–42) 36 (31–41) 94 (92–98) 99 (92–109) 92 (92–98) 99 (94–109)
CD4 T count, cells/μL 195 (45–332) (n = 10) 225 (45–332) (n = 9) 165 (n = 1) 1530 (1257–1833) 1631 (1530–1833) 1305 (1120–1502)
CD8 T count, cells/μL 1227 (973–1350) 1227 (973–1325) 1166 (972–1417)
HIV RNA, Iog10, coples/mL 5.4 (4.6–5.9)
a

Data was shown in n (%) or median (interquartile range, IQR)

b

“—”.